We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure coreplatform@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
By
Helen A.L. Tuppen, Wellcome Trust Centre for Mitochondrial Research, Institute for Ageing and Health, Newcastle University Medical School, Newcastle-upon-Tyne, UK,
Mary Herbert, Wellcome Trust Centre for Mitochondrial Research, Institute for Ageing and Health, Newcastle University, Bioscience Centre, International Centre for Life, Newcastle-upon-Tyne, UK,
Doug M. Turnbull, Wellcome Trust Centre for Mitochondrial Research, Institute for Ageing and Health, Newcastle University Medical School, Newcastle-upon-Tyne, UK
Present in all nucleated cells, mitochondria are essential subcellular organelles that play a crucial role in several different biochemical processes, including energy production. Mitochondria are believed to be evolutionary relics of ancient bacterial symbionts [1], and an important legacy of this history is the persistence within these organelles of a small genome, termed mitochondrial DNA (mtDNA). MtDNA is the only extranuclear source of DNA in the cell and it follows a different mode of inheritance from nuclear DNA. We highlight the important role of mitochondria in reproduction and why this small molecule of DNA presents so many interesting and important challenges particularly in reproductive biology.
Mitochondrial function
Mitochondria are double-membraned structures which are central to a multitude of biological functions in all nucleated mammalian cells, including the regulation of apoptotic cell death, the control of cytosolic calcium concentration, and the biogenesis of iron–sulfur clusters. Mitochondria are also the primary source of endogenous reactive oxygen species and they house several critical biochemical pathways, including the tricarboxylic acid cycle and part of the urea cycle. However, arguably the most important function of mitochondria is the production of ATP, the energy carrier of the cell, via oxidative phosphorylation (OXPHOS). OXPHOS requires the coordinated activity of five multi-subunit enzyme complexes located in the inner mitochondrial membrane. Electrons, resulting from the oxidation of fat and carbohydrates, are transported along complexes I–IV, thus creating an electrochemical gradient for protons across the inner mitochondrial membrane that drives the synthesis of ATP by complex V (ATP synthase).
The human prion diseases have traditionally been classified into Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler syndrome (GSS) and kuru. The clinically defined categories: CJD, GSS, and kuru may be divided further into three etiological categories: sporadic, acquired, and inherited. The coding sequences of mammalian prion protein genes are highly conserved in a similar way to other structural proteins, presumably by deleterious selection of coding mutations. Symptomatic treatment of various neurological and psychiatric features can be provided and a range of supportive services are likely to be required in the later stages of the disease. A number of approaches to rational therapeutics are being studied in experimental models. Anti-PrP antibodies have been shown to block progression of peripheral prion propagation in mouse models, and humanized versions of these antibodies could, in principle, be developed and used for both post-exposure prophylaxis and during established clinical disease.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.